Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Lanzillo

Showing results (161-170 of 210) with videos related to

Pageof 21
Sort By:
Annals of Clinical and Translational Neurology|June 12, 2025
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple SclerosisFortunata Carbone, Alessandra Colamatteo, Teresa Micillo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2015
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania regionChiara de Waure, Francesco Di Nardo, Walter Mazzucco, et al.
Journal of Clinical Medicine|April 3, 2021
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 OutbreakAntonio Carotenuto, Cristiano Scandurra, Teresa Costabile, et al.
Neuroradiology|April 8, 2017
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple SclerosisSirio Cocozza, Gaia Olivo, Eleonora Riccio, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2021
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison StudyAurora Zanghì, Antonio Gallo, Carlo Avolio, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2026
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatmentClaudia Russo, Clorinda Fusco, Fortunata Carbone, et al.
Plos One|March 28, 2015
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patientsFrancesco Patti, Manuela De Stefano, Luigi Lavorgna, et al.
Frontiers in Immunology|January 24, 2019
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple SclerosisAndrea Iannello, Simona Rolla, Alessandro Maglione, et al.
Journal of Neurology|June 8, 2020
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysisEmanuele D'Amico, Aurora Zanghì, Mariangela Sciandra, et al.
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Pageof 21

Showing results (161-170 of 210) with videos related to

Sort By:
Pageof 21
Annals of Clinical and Translational Neurology|June 12, 2025
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple SclerosisFortunata Carbone, Alessandra Colamatteo, Teresa Micillo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2015
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania regionChiara de Waure, Francesco Di Nardo, Walter Mazzucco, et al.
Journal of Clinical Medicine|April 3, 2021
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 OutbreakAntonio Carotenuto, Cristiano Scandurra, Teresa Costabile, et al.
Neuroradiology|April 8, 2017
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple SclerosisSirio Cocozza, Gaia Olivo, Eleonora Riccio, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2021
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison StudyAurora Zanghì, Antonio Gallo, Carlo Avolio, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2026
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatmentClaudia Russo, Clorinda Fusco, Fortunata Carbone, et al.
Plos One|March 28, 2015
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patientsFrancesco Patti, Manuela De Stefano, Luigi Lavorgna, et al.
Frontiers in Immunology|January 24, 2019
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple SclerosisAndrea Iannello, Simona Rolla, Alessandro Maglione, et al.
Journal of Neurology|June 8, 2020
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysisEmanuele D'Amico, Aurora Zanghì, Mariangela Sciandra, et al.
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Pageof 21